CG
AGN

Cynosure Group’s Allergan plc AGN Stock Holding History

Cynosure Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,857
Closed -$329K – 67
2020
Q1 		$329K Sell
1,857
-328
-15% -$61.8K 0.24% 47
2019
Q4 		$418K Hold
2,185
– – 0.22% 48
2019
Q3 		$368K Sell
2,185
-774
-26% -$126K 0.2% 51
2019
Q2 		$495K Buy
+2,959
New +$410K 0.23% 50

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Cynosure Group's AGN Position: Q2 2020 in Review

Cynosure Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,857 shares — an estimated $329K sold.

Cynosure Group first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $495K in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Cynosure Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Cynosure Group sold 1,857 Allergan plc shares in Q2 2020, an estimated $329K.
  • Cynosure Group first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Cynosure Group's Allergan plc position peaked at $495K in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Cynosure Group's 13F filing for Q2 2020, filed 10 Aug 2020.